The non-ergot derived dopamine agonist quinagolide in prevention of early ovarian hyperstimulation syndrome in IVF patients: a randomized, double-blind, placebo-controlled trial

Author: Busso Cristiano   Fernndez-Snchez Manuel   Garca-Velasco Juan Antonio   Landeras Jos   Ballesteros Augustn   Muoz Elkin   Gonzlez Sandra   Simn Carlos   Arce Joan-Carles   Pellicer Antonio  

Publisher: Oxford University Press

ISSN: 1460-2350

Source: Human Reproduction, Vol.25, Iss.4, 2010-04, pp. : 995-1004

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract